Opportunistic Cholesterol Gene Screens: Good in Theory Only?

(MedPage Today) — A small pilot program was not enough to prove that opportunistic genomic screening for familial hypercholesterolemia (FH) put a dent in people’s cholesterol.
In the Million Veteran Program Return Of Actionable Results (ROAR…

Source link : https://www.medpagetoday.com/genetics/genetictesting/119353

Author :

Publish date : 2026-01-09 16:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

FDA Moves to ‘Get Out of the Way’ of Wearables, AI in the Clinic

Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests

Related Posts

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Beyond the Paywall: The Cost of Lack of Research Access

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Beyond the Paywall: The Cost of Lack of Research Access

To Fix a Patient’s Irregular Heartbeat, Doctors First Tested Its Digital ‘Twin’

An Unusual Case of Pneumonia on ‘The Pitt’: An Emergency Doctor Weighs In

Categories

Archives